[1]李金云,安玉美,王秀萍.孕妇参与产前筛查与诊断技术决策的研究进展[J].军事护理,2022,39(10):91-94.[doi:10.3969/j.issn.2097-1826.2022.10.024]
点击复制

孕妇参与产前筛查与诊断技术决策的研究进展
分享到:

《军事护理》[ISSN:2097-1826/CN:31-3186/R]

卷:
39
期数:
2022年10期
页码:
91-94
栏目:
综述
出版日期:
2022-10-15

文章信息/Info

Title:
Research Progress of Pregnant Women's Participation in Decisions-making Process of Prenatal Screening and Diagnostic Technology
文章编号:
2097-1826(2022)10-0091-04
作者:
李金云1安玉美2王秀萍3
(1.山东潍坊医学院附属医院 产前诊断中心,山东 潍坊261031; 2.山东潍坊医学院附属医院 影像中心; 3.山东潍坊医学院附属医院 供应室)
关键词:
孕妇参与 产前筛查 诊断技术决策
分类号:
R473.71
DOI:
10.3969/j.issn.2097-1826.2022.10.024
文献标志码:
A

参考文献/References:

[1] MOLINA F,DEHLENDORF C,GREGORICH S E,et al.Women's preferences for and experiences with prenatal genetic testing decision making:sociodemographic disparities in preference-concordant decision making[J].Patient Educ Couns,2019,102(3):595-601.
[2] 肖葛根.吉林省某医院产前诊断孕妇筛查与诊断技术认知状况调查[J].医学与社会,2018,31(7):64-67.
[3] 肖葛根.产前筛查与诊断技术选择中医患共同决策应用探讨[J].医学与哲学:B,2018,39(5):1-5.
[4] YU L,YANG S,ZHANG C,et al.Decision aids for prenatal testing:a systematic review and Meta-analysis[J].J Adv Nurs,2021,77(10):3964-3979.
[5] HILL M,JOHNSON J A,LANGLOIS S,et al.Preferences for prenatal tests for down syndrome:an international comparison of the views of pregnant women and health professionals[J].Eur J Hum Genet,2016; 24(7):968-975.
[6] DONG D,AHMED S,NICHINI E,et al.Decision making on antenatal screening results:a comparative Q-method study of women from two Chinese cities[J].Health Expect,2021,24(2):363-376.
[7] 李长娥.基于渥太华决策支持框架的孕妇产前筛查与诊断决策辅助工具编制[D].济南:山东大学,2021.
[8] HUANG W H,SHIH S F,LIN C L,et al.Pregnant women's attitudes and decision-making regarding prenatal down syndrome screening and diagnosis:scale development and validation[J/OL].[2022-01-20].https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-020-03093-6.DOI:10.1186/s12884-020-03093-6.
[9] MARTEAU T M,DORMANDY E,MICHIE S.A measure of informed choice[J].Health Expect,2001,4(2):99-108.
[10]SKJOTH M M,DRABORG E,LAMONT R F,et al.Informed choice about down syndrome screening- effect of an eHealth tool:a randomized controlled trial[J].Acta Obstet Gynecol Scand,2015,94(12):1327-1336.
[11]GOUROUNTI K,SANDALL J.The validation and translation of multidimensional measure of informed choice in Greek[J].Midwifery,2011,27(2):170-173.
[12]LEWIS C,HILL M,SKIRTON H,et al.Development and validation of a measure of informed choice for women undergoing non-invasive prenatal testing for aneuploidy[J].Eur J Hum Genet,2016,24(6):809-816.
[13]SHILOH S,AVDOR O,GOODMAN R M.Satisfaction with genetic counseling:dimensions and measurement[J].Am J Med Genet,1990,37(4):522-529.
[14]NORDIN K,LIDEN A,HANSSON M,et al.Coping style,psychological distress,risk perception,and satisfaction in subjects attending genetic counselling for hereditary cancer[J].J Med Genet,2002,39(9):689-694.
[15]HARTWIG T S,BORREGAARD MILTOFT C,MALMGREN C I,et al.High risk-what's next?A survey study on decisional conflict,regret,and satisfaction among high-risk pregnant women making choices about further prenatal testing for fetal aneuploidy[J].Prenat Diagn,2019,39(8):635-642.
[16]RABIEE M,JOUHARI Z,PIRASTEH A.Knowledge of prenatal screening,down syndrome,amniocentesis,and related factors among Iranian pregnant women:a cross-sectional study[J].Int J Community Based Nurs Midwifery,2019,7(2):150-160.
[17]蒲星伊,田梅,陈远玲.城市孕妇对无创产前基因检测胎儿染色体异常的认知水平及接受程度调查[J].华南预防医学,2019,45(5):432-435,496.
[18]KATER-KUIPERS A,BUNNIK E M,DE BEAUFORT I D,et al.Limits to the scope of non-invasive prenatal testing(NIPT):an analysis of the international ethical framework for prenatal screening and an interview study with Dutch professionals[J/OL].[2022-01-20].https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-018-2050-4.DOI:10.1186/s12884-018-2050-4.
[19]CHUONG N C,DUC D M,ANH N D,et al.Amniocentesis test uptake for congenital defects:decision of pregnant women in Vietnam[J].Health Care Women Int,2018,39(4):493-504.
[20]SADLECKI P,GRABIEC M,WALENTOWICZ P,et al.Why do patients decline amniocentesis?Analysis of factors influencing the decision to refuse invasive prenatal testing[J/OL].[2022-01-20].https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-018-1812-3.DOI:10.1186/s12884-018-1812-3.
[21]LUND I C B,BECHER N,PETERSEN O B,et al.Preferences for prenatal testing among pregnant women,partners and health professionals[J/OL].[2022-01-20].https://ugeskriftet.dk/dmj/preferences-prenatal-testing-among-pregnant-women-partners-and-health-professionals.
[22]SEROR V,L'HARIDON O,BUSSIERES L,et al.Women's attitudes toward invasive and noninvasive testing when facing a high risk of fetal down syndrome[J/OL].[2022-01-20].https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2729472.DOI:10.1001/jamanetworkopen.2019.1062.
[23]VANSTONE M,CERNAT A,MAJID U,et al.Perspectives of pregnant people and clinicians on noninvasive prenatal testing:a systematic review and qualitative meta-synthesis[J].Ont Health Technol Assess Ser,2019,19(5):1-38.
[24]OGAMBA C F,BABAH O A,ROBERTS A A,et al.Knowledge,attitudes,and decision making towards prenatal testing among antenatal clinic attendees in Lagos University Teaching Hospital:an institution-based cross-sectional study[J/OL].[2022-01-20].https://www.panafrican-med-journal.com/content/article/39/106/full/.DOI:10.11604/pamj.2021.39.106.23667.
[25]CHEN A,TENHUNEN H,TORKKI P,et al.Facilitating autonomous,confident and satisfying choices:a mixed-method study of women's choice-making in prenatal screening for common aneuploidies[J/OL].[2022-01-20].https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-018-1752-y.DOI:10.1186/s12884-018-1752-y.
[26]STOLL K,JACKSON J.Supporting patient autonomy and informed decision-making in prenatal genetic testing[J/OL].[2022-01-20].http://perspectivesinmedicine.cshlp.org/content/10/6/a036509.long.DOI:10.1101/cshperspect.a036509.
[27]WATANABE M,MATSUO M,OGAWA M,et al.Genetic counseling for couples seeking noninvasive prenatal testing in Japan:experiences of pregnant women and their partners[J].J Genet Couns,2017,26(3):628-639.
[28]YESILCINAR I,GUVENC G.Counselling and education for prenatal screening and diagnostic tests for pregnant women:randomized controlled trial[J/OL].[2022-01-20].https://onlinelibrary.wiley.com/doi/10.1111/ijn.13000.DOI:10.1111/ijn.13000.
[29]GAMMON B L,OTTO L,WICK M,et al.Implementing group prenatal counseling for expanded noninvasive screening options[J].J Genet Couns,2018,27(4):894-901.
[30]KORDI M,RIYAZI S,LOTFALIZADE M,et al.A comparison of face to face and group education on informed choice and decisional conflict of pregnant women about screening tests of fetal abnormalities[J/OL].[2022-01-20].https://www.jehp.net/article.asp?issn=2277-9531; year=2018; volume=7; issue=1; spage=6; epage=6; aulast=Kordi.DOI:10.4103/jehp.jehp_106_15.
[31]ROTHWELL E,JOHNSON E,WONG B,et al.The use of a game-based decision aid to educate pregnant women about prenatal screening:a randomized controlled study[J].Am J Perinatol,2019,36(3):322-328.
[32]SMITH S K,CAI A,WONG M,et al.Improving women's knowledge about prenatal screening in the era of non-invasive prenatal testing for Down syndrome - development and acceptability of a low literacy decision aid[J/OL].[2022-01-20].https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-018-2135-0.DOI:10.1186/s12884-018-2135-0.
[33]PORTOCARRERO M E,GIGUERE A M,LEPINE J,et al.Use of a patient decision aid for prenatal screening for down syndrome:what do pregnant women say?[J/OL].[2022-01-20].https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-017-1273-0.DOI:10.1186/s12884-017-1273-0.
[34]HERRON A P,AGBADJE T T,COTE M,et al.Web-based training for nurses on shared decision making and prenatal screening for down syndrome:protocol for a randomized controlled trial[J/OL].[2022-01-20].https://www.researchprotocols.org/2020/10/e17878/.DOI:10.2196/17878.

备注/Memo

备注/Memo:
【 收稿日期 】 2022-02-23 【 修回日期 】 2022-09-07
【 基金项目 】 潍坊市软科学研究计划项目(2021RKX150)
【 作者简介 】 李金云,硕士,主管护师,从事妇产科护理工作
更新日期/Last Update: 2022-10-15